RT-qPCR analysis of laser capture micro-dissected material from CD31 stained FFPE tissue sections

Size: px
Start display at page:

Download "RT-qPCR analysis of laser capture micro-dissected material from CD31 stained FFPE tissue sections"

Transcription

1 RT-qPCR analysis of laser capture micro-dissected material from CD31 stained FFPE tissue sections Julian Schuster, Beatrix Bahle, Andrea Herold, Sabine Lohmann Roche Innovation Center Penzberg, Germany 4 th Munich Biomarker Conference, November 25 th 2014

2 RT-qPCR analysis of laser capture micro-dissected material from CD31 stained FFPE tissue sections Scientific Rationale Method Development: Combining histological staining of FFPET with LCM & RT-qPCR Introducing additional complexity: CD31 IHC staining Summary

3 Scientific Rationale Complementary roles of Ang2 & VEGF-A in tumor angiogenesis 3

4 Schematic representation of Ang2-VEGF-A CrossMab Blocking VEGF-A and Ang-2 function simultaneously VEGF-A VEGF-A Ang-2 Ang-2 Ang-2 Ang-2 CH1 Ck cross anti-vegf-a = Avastin anti-ang-2 = LC06 Ang-2 crossed (CH1-Cκ crossover) Fab domain knobs into holes original bevacizumab (Avastin) light chain Kiennast et al. 2013; Clin Cancer Res Dec 15;19(24): doi: / CCR

5 Hypothesis/Rationale for Biomarker Study: Ang-2 & Tie 2 Expression Differential Ang2 & Tie2 Gene Expression is described in literature for various tumor entities and/or tumor-associated endothelial cells (EC): Cellular model systems 1 Xenograft model systems (Colorectal cancer & melanoma) 2 Glioblastoma 3 Melanoma 4 Breast Cancer 5 Hypothesis for prediction of response to anti-angiogenic therapy described by Helfrich et al. 6 Low angiogenic tumors Reduced levels of pro-angiogenic factors & their receptors in endothelial cells Low-vascularized tumors Association with resistance to α-vegf therapy High angiogenic tumors High levels of pro-angiogenic factors & their receptors in endothelial cells High-vascularized tumors Enhanced sensitivity of intra-tumoral micro-vessels to α-vegf therapy 1) Scharpfenecker et al. J Cell Sci 2005; Fiedler et al. Blood ) Fathers et al. AJP ) Stratmann et. al. Am. J Pathol 1998; Zadeh et al. AJP ) Helfrich et al., Clin Cancer Res ) Dales et al.,int. J Oncol ) Helfrich et. al. JEM 2010, 5

6 RT-qPCR analysis of laser capture micro-dissected material from CD31 stained FFPE tissue sections Scientific Rationale Method Development: Combining histological staining of FFPET with LCM & RT-qPCR Introducing additional complexity: CD31 IHC staining Summary

7 Tumor Heterogeneity Whole FFPET Slide versus micro-dissected material Separation of vessels and tumor cell nests from CD31 stained tissue NSCLC CD31 stained Tumor cell nests [1mm 2 to be collected] Vessels

8 Separation of Tumor Cells and Vessels via LCM* Prior to analysis of Ang-2 and Tie2 gene expression by RT-qPCR NSCLC FFPET section CD31 stained *Laser Capture Microdisscection

9 Workflow Description Isolation of tumor cells & vessels from FFPET tissue samples by LCM followed RT-qPCR analysis 9 Sectioning Deparaffinization Laser Capture RNA Isolation cdna Synthesis qpcr & Staining Microdissection (LCM) Microtome Xylene NSCLC FFPE tissue samples 5 µm sections on membrane slides Staining with Methyl green Dissect region of interest (tumor, vessel) High Pure FFPET RNA Isolation Kit Specific Multiplex multiplex cdna cdna synthesis priming (rev Primer) Transcriptor 1. strand cdna synthesis Kit Rel. Quantification Ang2,Tie2/HPRT (target/reference) Dedicated RealTime ready Assays

10 Ang2 & Tie2 are predominantly expressed in Vessels rather than in Tumor Cells Methyl green staining Ang2 expression Tie2 expression Gene expression in isolated vessels (RED) and tumor cells (BLUE) after cell separation via LCM from NSCLC samples 10

11 RT-qPCR analysis of laser capture micro-dissected material from CD31 stained FFPE tissue sections Scientific Rationale Method Development: Combining histological staining of FFPET with LCM & PCR Introducing additional complexity: CD31 IHC staining Summary

12 High salt buffer stabilizes RNA during IHC staining spectral photometric concentration analysis of isolated RNA. 40,00 35,00 30,00 concentration [ng/µl] 25,00 20,00 15,00 10,00 5,00 not stained CD31 staining without NaCl CD31 staining with NaCl 0,00

13 High salt buffer during IHC staining stabilizes RNA RT-qPCR analysis for 2 reference genes

14 Key Steps in Methods Development 1) High salt buffer for IHC staining procedure: comprising sodium chloride in a concentration of M 2) Coating of membrane slides with poly-l-lysine poly-l-lysine coating to attach tissue to the membrane slide during low temperature heat induced epitope retrieval (LT-HIER)

15 Workflow Description RT-qPCR analysis of micro-dissected material from CD31 stained FFPET sections Microtome Sectioning NSCLC FFPE tissue samples 5 µm sections on membrane slides RNA Isolation trna Deparaffinization Xylene cdna Synthesis Random hexamer + Oligo dt IHC Staining compatible membrane slides & RNA isolation Pre-Amplification Specific primer pool Laser Capture Microdissection (LCM) From CD31 stained FFPET sections qpcr Rel. Quantification Dedicated RealTime ready Assays

16 Workflow Description RT-qPCR analysis of micro-dissected material from CD31 stained FFPET sections Microtome Sectioning NSCLC FFPE tissue samples 5 µm sections on membrane slides RNA Isolation trna Deparaffinization Xylene cdna Synthesis Random hexamer + Oligo dt IHC Staining compatible membrane slides & RNA isolation Pre-Amplification Specific primer pool Laser Capture Microdissection (LCM) From CD31 stained FFPET sections qpcr Rel. Quantification Ang2,Tie2/ALAS1, HPRT Dedicated RealTime ready Assays 16

17 Ang2 & Tie2 are predominantly expressed in Vessels rather than in Tumor Cells CD31 stained NSCLC samples Ratio ANG ANG2 - Tumor 0 0 0,52 ANG2 - Vessels 73,65 15, Ratio TIE2 0,9 0,8 0,7 0,6 0,5 0,4 0,3 0,2 0, TIE2- Tumor TIE2 - Vessels 0,788 0,5703 0,68 The CD31 stained vessels were identified to express Ang2 and Tie2. The results from the previous study could be reproduced. We used the identical NSCLC samples as in the previous Ang2-VEGF study. 17

18 Molecular Pathology: Angiopoietin-2 and VEGF-A Two major players in tumor angiogenesis and growth Ang-2 Ang-2 is expressed by endothelial cells (vasculature) Tie2 VEGFR-2 VEGF-A VEGF-A is mainly produced by tumor cells Modified from Folkman J, Angiogenesis: an organizing principle for drug discovery?, Nature Reviews Drug Discovery 6, (April 2007) 18

19 RT-qPCR analysis of laser capture micro-dissected material from CD31 stained FFPE tissue sections Conclusions & Outlook A CD 31 staining procedure that can be applied for FFPE NSCLC tissue on membrane slides, that is compatible with subsequent LCM, RNA isolation & RT-qPCR has been developed. Limited sample number, no statistics Optimize IHC staining method for each marker and tumor tissue type Very labour-intensive workflow Not applicable for high sample numbers Suitable for Biomarker hypothesis generation Alternative/additional down stream application opportunities should be possible: - Profiling/arrays - Sequencing - qpcr/dna analysis

20 Thank you to Biomarker Team at Diagnostics Pharma Research Early Development Julian Schuster Beatrix Bahle Gisela Betzl Caroline Sirsch Viola Mayer-Hoyle Andrea Herold Sabine Moosmann Monika Singer Suzanna Vega-Haring Lisa Coulten Astrid Köhler

21 Doing now what patients need next

Workflow. Connecting the Pieces For Total Patient Care

Workflow. Connecting the Pieces For Total Patient Care Workflow Connecting the Pieces For Total Patient Care Biocare provides a full line of IHC and molecular pathology products for cancer and infectious disease diagnosis. From a full range of equipment: including

More information

ExpressArt FFPE Clear RNAready kit

ExpressArt FFPE Clear RNAready kit Features and Example Results General problems with FFPE samples Formalin-fixation of tissues results in severe RNA fragmentation, as well as in RNA RNA, RNA-DNA and RNA protein cross-linking, which impairs

More information

Next-Generation Immunohistochemistry: Multiplex tissue imaging with mass cytometry

Next-Generation Immunohistochemistry: Multiplex tissue imaging with mass cytometry Nat Met, April 2014 Nat Med, April 2014 Next-Generation Immunohistochemistry: Multiplex tissue imaging with mass cytometry Journal Club Timo Böge Overview Introduction Conventional Immunohistochemistry

More information

A complete next-generation sequencing workfl ow for circulating cell-free DNA isolation and analysis

A complete next-generation sequencing workfl ow for circulating cell-free DNA isolation and analysis APPLICATION NOTE Cell-Free DNA Isolation Kit A complete next-generation sequencing workfl ow for circulating cell-free DNA isolation and analysis Abstract Circulating cell-free DNA (cfdna) has been shown

More information

DNA Methylation of Tumor Suppressor and Metastasis Suppressor Genes in Circulating Tumor Cells and corresponding Circulating Tumor DNA

DNA Methylation of Tumor Suppressor and Metastasis Suppressor Genes in Circulating Tumor Cells and corresponding Circulating Tumor DNA DNA Methylation of Tumor Suppressor and Metastasis Suppressor Genes in Circulating Tumor Cells and corresponding Circulating Tumor DNA Maria Chimonidou 1, Areti Strati 1, Nikos Malamos 2, Vasilis Georgoulias

More information

OMP-305B83: A Novel, Potent DLL4 & VEGF Targeting Bispecific Antibody for the Treatment Of Solid Tumors

OMP-305B83: A Novel, Potent DLL4 & VEGF Targeting Bispecific Antibody for the Treatment Of Solid Tumors OMP-305B83: A Novel, Potent DLL4 & VEGF Targeting Bispecific Antibody for the Treatment Of Solid Tumors Jakob Dupont MD MA CMO, SVP: OncoMed Pharmaceuticals Adjunct Clinical Faculty: Stanford University

More information

Immune Cell Phenotyping in Solid Tumors using Quantitative Pathology

Immune Cell Phenotyping in Solid Tumors using Quantitative Pathology Immune Cell Phenotyping in Solid Tumors using Quantitative Pathology James R. Mansfield Director of Quantitative Pathology Applications 2009 PerkinElmer What is Quantitative Pathology? Quantitative Pathology

More information

microrna Presented for: Presented by: Date:

microrna Presented for: Presented by: Date: microrna Presented for: Presented by: Date: 2 micrornas Non protein coding, endogenous RNAs of 21-22nt length Evolutionarily conserved Regulate gene expression by binding complementary regions at 3 regions

More information

2/1/2017. Agenda. David F. Williams, MD, MBA. History of Current Treatment. Current Treatment/Wet AMD Anti-VEGF Drugs. History of Current Treatment

2/1/2017. Agenda. David F. Williams, MD, MBA. History of Current Treatment. Current Treatment/Wet AMD Anti-VEGF Drugs. History of Current Treatment UPDATE ON CLINICAL TRIALS FOR AMD David F. Williams, MD, MBA Agenda Brief History of Current Rx Recently Completed/New CTs: Wet AMD Recently Completed/New CTs: Dry AMD Current Treatment/Wet AMD Anti-VEGF

More information

The Angiopoietin Axis in Cancer

The Angiopoietin Axis in Cancer Ang2 Ang1 The Angiopoietin Axis in Cancer Tie2 An Overview: The Angiopoietin Axis Plays an Essential Role in the Regulation of Tumor Angiogenesis Growth of a tumor beyond a limiting size is dependent upon

More information

AbSeq on the BD Rhapsody system: Exploration of single-cell gene regulation by simultaneous digital mrna and protein quantification

AbSeq on the BD Rhapsody system: Exploration of single-cell gene regulation by simultaneous digital mrna and protein quantification BD AbSeq on the BD Rhapsody system: Exploration of single-cell gene regulation by simultaneous digital mrna and protein quantification Overview of BD AbSeq antibody-oligonucleotide conjugates. High-throughput

More information

Biomarker strategy for Personalized Healthcare at Roche

Biomarker strategy for Personalized Healthcare at Roche Biomarker strategy for Personalized Healthcare at Roche E mi l i a An d e r sso n o n b e h a l f o f t h e I R I S t e a m No v 2 0 1 6 6th Munich Biomarker Conference Nov 29th 30th, 2016 Ramada Hotel

More information

Instructions for Use. RealStar Influenza S&T RT-PCR Kit /2017 EN

Instructions for Use. RealStar Influenza S&T RT-PCR Kit /2017 EN Instructions for Use RealStar Influenza S&T RT-PCR Kit 3.0 01/2017 EN RealStar Influenza S&T RT-PCR Kit 3.0 For research use only! (RUO) 163003 INS-163000-EN-S02 96 01 2017 altona Diagnostics GmbH Mörkenstr.

More information

XTRAKT FFPE Kit / Manual

XTRAKT FFPE Kit / Manual XTRAKT FFPE Kit / Manual For manual extraction of RNA, mirna and/or DNA from Formalin Fixed Paraffin Embedded (FFPE) tissue samples Catalog No. # XTK2.0-96 For research use only. Not intended for diagnostic

More information

HIF-P4H-2 deficiency protects against skeletal muscle ischemia-reperfusion injury

HIF-P4H-2 deficiency protects against skeletal muscle ischemia-reperfusion injury J Mol Med 2015 HIF-P4H-2 deficiency protects against skeletal muscle ischemia-reperfusion injury Sara Karsikas; Mikko Myllymäki; Minna Heikkilä; Raija Sormunen; Kari I Kivirikko; Johanna Myllyharju; Raisa

More information

AVENIO family of NGS oncology assays ctdna and Tumor Tissue Analysis Kits

AVENIO family of NGS oncology assays ctdna and Tumor Tissue Analysis Kits AVENIO family of NGS oncology assays ctdna and Tumor Tissue Analysis Kits Accelerating clinical research Next-generation sequencing (NGS) has the ability to interrogate many different genes and detect

More information

Comparison of depth-specific gene expression levels in primary tumors in advanced gastric cancer

Comparison of depth-specific gene expression levels in primary tumors in advanced gastric cancer Original Contribution Kitasato Med J 2014; 44: 125-133 Comparison of depth-specific gene expression levels in primary tumors in advanced gastric cancer Akira Naruke, 1 Mizutomo Azuma, 1 Atsuko Takeuchi,

More information

B16F1 B16F10 Supplemental Figure S1

B16F1 B16F10 Supplemental Figure S1 B16F1 B16F1 Supplemental Figure S1 Representative microangiography images of B16F1 and B16F1 tumors grown in the cranial windows. FITC-dextran (2 million MW) was injected systemically to visualize blood

More information

Gene expression profiling in single cells

Gene expression profiling in single cells Gene expression profiling in single cells Anders Ståhlberg Department of Chemistry & Biosciences / Molecular Biotechnology Chalmers University of Technology Outline Technical considerations Gene expression

More information

Results you can trust

Results you can trust PRODUCT I NF OR MAT ION pharmdx Results you can trust The first and only FDA-approved PD-L1 test to assess the magnitude of treatment effect on progression-free survival in melanoma patients from OPDIVO

More information

Incorporating pharmacodynamic, response and patient selection biomarkers. Paul Elvin PhD Chief Translational Science Officer Aptus Clinical

Incorporating pharmacodynamic, response and patient selection biomarkers. Paul Elvin PhD Chief Translational Science Officer Aptus Clinical Incorporating pharmacodynamic, response and patient selection biomarkers Paul Elvin PhD Chief Translational Science Officer Aptus Clinical 22 Oncology drug development Biomarkers key for: Strong hypothesis

More information

WHO Prequalification of In Vitro Diagnostics PUBLIC REPORT. Product: Alere q HIV-1/2 Detect WHO reference number: PQDx

WHO Prequalification of In Vitro Diagnostics PUBLIC REPORT. Product: Alere q HIV-1/2 Detect WHO reference number: PQDx WHO Prequalification of In Vitro Diagnostics PUBLIC REPORT Product: Alere q HIV-1/2 Detect WHO reference number: PQDx 0226-032-00 Alere q HIV-1/2 Detect with product codes 270110050, 270110010 and 270300001,

More information

Cancer Metronomic Therapy Milan, February 26, 2016

Cancer Metronomic Therapy Milan, February 26, 2016 Cancer Metronomic Therapy Milan, February 26, 2016 Metronomic Chemotherapy: Evolution and Development of the Concept Robert S. Kerbel, PhD Senior Scientist Sunnybrook Research Institute Professor, Dept.

More information

RNA preparation from extracted paraffin cores:

RNA preparation from extracted paraffin cores: Supplementary methods, Nielsen et al., A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor positive breast cancer.

More information

Molecular Probes Introducing 14 new probes

Molecular Probes Introducing 14 new probes Molecular Probes Introducing 14 new probes Gene and Chromosome Probes Dual Colour ISH INFORM HER2 Dual ISH DNA Probe Cocktail Assay Product Part Number INFORM HER2 Dual ISH DNA Probe Cocktail 800-4422

More information

UNIVERSITY OF MEDICINE AND PHARMACY CRAIOVA PhD SCHOOL. PhD THESIS

UNIVERSITY OF MEDICINE AND PHARMACY CRAIOVA PhD SCHOOL. PhD THESIS UNIVERSITY OF MEDICINE AND PHARMACY CRAIOVA PhD SCHOOL PhD THESIS THE IMPORTANCE OF TUMOR ANGIOGENESIS IN CEREBRAL TUMOR DIAGNOSIS AND THERAPY ABSTRACT PhD COORDINATOR: Prof. univ. dr. DRICU Anica PhD

More information

Instructions for Use. RealStar Influenza Screen & Type RT-PCR Kit /2017 EN

Instructions for Use. RealStar Influenza Screen & Type RT-PCR Kit /2017 EN Instructions for Use RealStar Influenza Screen & Type RT-PCR Kit 4.0 05/2017 EN RealStar Influenza Screen & Type RT-PCR Kit 4.0 For research use only! (RUO) 164003 INS-164000-EN-S01 96 05 2017 altona

More information

The Presence and Persistence of Resistant and Stem Cell- Like Tumor Cells as a Major Problem in Ovarian Cancer

The Presence and Persistence of Resistant and Stem Cell- Like Tumor Cells as a Major Problem in Ovarian Cancer Welcome! The Presence and Persistence of Resistant and Stem Cell- Like Tumor Cells as a Major Problem in Ovarian Cancer Prof. Sabine Kasimir-Bauer Department of Gynecology and Obstetrics University Hospital

More information

RD-100i OSNA the new generation of sentinel lymph node analysis in breast cancer

RD-100i OSNA the new generation of sentinel lymph node analysis in breast cancer RD-1i OSNA the new generation of sentinel lymph node analysis in breast cancer RD-1i OSNA the new generation of sentinel lymph node analysis in breast cancer Sentinel node biopsy has rapidly emerged as

More information

Inhibitors of Methionine Aminopeptidase-2 2 in the Treatment of Non-Hodgkin

Inhibitors of Methionine Aminopeptidase-2 2 in the Treatment of Non-Hodgkin Inhibitors of Methionine Aminopeptidase-2 2 in the Treatment of Non-Hodgkin Hodgkin s s Lymphoma Targeted Cancer Therapies William Westlin, Ph.D. Vice President, Preclinical Research Discovery of Fumagillin

More information

Central Pathology Review and Tissue MicroArrays. Dr Lisa Storer Children s Brain Tumour Research Centre Nottingham

Central Pathology Review and Tissue MicroArrays. Dr Lisa Storer Children s Brain Tumour Research Centre Nottingham Central Pathology Review and Tissue MicroArrays Dr Lisa Storer Children s Brain Tumour Research Centre Nottingham What is a tissue microarray? Tissue microarrays (TMAs) consist of paraffin blocks in which

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Fumagalli D, Venet D, Ignatiadis M, et al. RNA Sequencing to predict response to neoadjuvant anti-her2 therapy: a secondary analysis of the NeoALTTO randomized clinical trial.

More information

(A) PCR primers (arrows) designed to distinguish wild type (P1+P2), targeted (P1+P2) and excised (P1+P3)14-

(A) PCR primers (arrows) designed to distinguish wild type (P1+P2), targeted (P1+P2) and excised (P1+P3)14- 1 Supplemental Figure Legends Figure S1. Mammary tumors of ErbB2 KI mice with 14-3-3σ ablation have elevated ErbB2 transcript levels and cell proliferation (A) PCR primers (arrows) designed to distinguish

More information

Avastin (bevacizumab)

Avastin (bevacizumab) Avastin (bevacizumab) Policy Number: 5.02.502 Last Review: 04/2018 Origination: 03/2017 Next Review: 04/2019 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage for Avastin

More information

Individualized Cancer Therapy: Chemotherapy Resistance Testing before Therapy

Individualized Cancer Therapy: Chemotherapy Resistance Testing before Therapy Individualized Cancer Therapy: Chemotherapy Resistance Testing before Therapy 1 st st International Oncological Conference Wrocław, October 6 th, 2012 Dr. Frank Kischkel Individualized Cancer Therapy:

More information

Evolution of Pathology

Evolution of Pathology 1 Traditional pathology Molecular pathology 2 Evolution of Pathology Gross Pathology Cellular Pathology Morphologic Pathology Molecular/Predictive Pathology Antonio Benivieni (1443-1502): First autopsy

More information

Direct Evidence that Bevacizumab, an Anti-VEGF Antibody, Upregulates SDF1, CXCR4, CXCL6, and Neuropilin 1 in Tumors from Patients with Rectal Cancer

Direct Evidence that Bevacizumab, an Anti-VEGF Antibody, Upregulates SDF1, CXCR4, CXCL6, and Neuropilin 1 in Tumors from Patients with Rectal Cancer Direct Evidence that Bevacizumab, an Anti-VEGF Antibody, Upregulates SDF1, CXCR4, CXCL6, and Neuropilin 1 in Tumors from Patients with Rectal Cancer The Harvard community has made this article openly available.

More information

Cellecta Overview. Started Operations in 2007 Headquarters: Mountain View, CA

Cellecta Overview. Started Operations in 2007 Headquarters: Mountain View, CA Cellecta Overview Started Operations in 2007 Headquarters: Mountain View, CA Focus: Development of flexible, scalable, and broadly parallel genetic screening assays to expedite the discovery and characterization

More information

SMH (Myosin, smooth muscle heavy chain)

SMH (Myosin, smooth muscle heavy chain) Material The slide to be stained for SMH comprised: Assessment Run 50 2017 SMH (Myosin, smooth muscle heavy chain) 1.Tonsil, 2. Esophagus, 3. Breast hyperplasia, 4. Breast ductal carcinoma in situ (DCIS),

More information

1. The metastatic cascade. 3. Pathologic features of metastasis. 4. Therapeutic ramifications. Which malignant cells will metastasize?

1. The metastatic cascade. 3. Pathologic features of metastasis. 4. Therapeutic ramifications. Which malignant cells will metastasize? 1. The metastatic cascade 3. Pathologic features of metastasis 4. Therapeutic ramifications Sir James Paget (1814-1899) British Surgeon/ Pathologist Paget s disease of Paget s disease of the nipple (intraductal

More information

Molecular Profiling of Tumor Microenvironment Alex Chenchik, Ph.D. Cellecta, Inc.

Molecular Profiling of Tumor Microenvironment Alex Chenchik, Ph.D. Cellecta, Inc. Molecular Profiling of Tumor Microenvironment Alex Chenchik, Ph.D. Cellecta, Inc. Cellecta, Inc. Founded: April 2006 Headquarters: Mountain View, CA 12 SBIR Grants Custom Service Provider for Functional

More information

Protocol: specimen preparation (brain dissection and region extraction) for using RT-qPCR to examine gene expression in brain regions of a fish

Protocol: specimen preparation (brain dissection and region extraction) for using RT-qPCR to examine gene expression in brain regions of a fish HOST LAB: DR. LAUREN O'CONNELL, CENTER FOR SYSTEMS BIOLOGY, HARVARD UNIVERSITY Protocol: specimen preparation (brain dissection and region extraction) for using RT-qPCR to examine gene expression in brain

More information

The CellCollector TM technology

The CellCollector TM technology The CellCollector TM technology In vivo isolation of circulating tumor cells by the CellCollector TM system Dr. Klaus Lücke (CEO) Unmet medical need in oncology: Access to tumor cells not only at the time

More information

Development of Rational Drug Combinations for Oncology Indications - An Industry Perspective

Development of Rational Drug Combinations for Oncology Indications - An Industry Perspective Development of Rational Drug Combinations for Oncology Indications An Industry Perspective Stuart Lutzker, MDPhD Vice President Oncology Early Development Genentech Inc 1 Conventional Oncology Drug Development

More information

RD-100i OSNA the new generation of sentinel lymph node analysis in breast cancer

RD-100i OSNA the new generation of sentinel lymph node analysis in breast cancer RD-1i OSNA the new generation of sentinel lymph node analysis in breast cancer www.sysmex-europe.com RD-1i OSNA the new generation of sentinel lymph node analysis in breast cancer Sentinel node biopsy

More information

Profiles of gene expression & diagnosis/prognosis of cancer. MCs in Advanced Genetics Ainoa Planas Riverola

Profiles of gene expression & diagnosis/prognosis of cancer. MCs in Advanced Genetics Ainoa Planas Riverola Profiles of gene expression & diagnosis/prognosis of cancer MCs in Advanced Genetics Ainoa Planas Riverola Gene expression profiles Gene expression profiling Used in molecular biology, it measures the

More information

Simple, rapid, and reliable RNA sequencing

Simple, rapid, and reliable RNA sequencing Simple, rapid, and reliable RNA sequencing RNA sequencing applications RNA sequencing provides fundamental insights into how genomes are organized and regulated, giving us valuable information about the

More information

The use of diagnostic FFPE material in cancer epidemiology research

The use of diagnostic FFPE material in cancer epidemiology research The use of diagnostic FFPE material in cancer epidemiology research Neil O Callaghan Genetic Epidemiology Laboratory Department of Pathology The University of Melbourne www.pedigree.org.au Overview Who

More information

Zurich Open Repository and Archive

Zurich Open Repository and Archive University of Zurich Zurich Open Repository and Archive Winterthurerstr. 190 CH-8057 Zurich http://www.zora.uzh.ch Year: 2010 Laser-capture microdissection impairs activity-based protein profiles for serine

More information

Angiogenesis and tumor growth

Angiogenesis and tumor growth Anti-angiogenic agents: where we are? Martin Reck Department of Thoracic Oncology Hospital Grosshansdorf Germany Angiogenesis and tumor growth Journal of experimental Medicine 1972; 133: 275-88 1 Angiogenesis

More information

Angiogenesis as a therapeutic target

Angiogenesis as a therapeutic target Angiogenesis as a therapeutic target Lecture Experimentelle Krebsforschung SS 07 Prof. Gerhard Christofori Institute of Biochemistry and Genetics Department of Clinical-Biological Sciences University of

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION SUPPLEMENTARY INFORMATION FOR Liver X Receptor α mediates hepatic triglyceride accumulation through upregulation of G0/G1 Switch Gene 2 (G0S2) expression I: SUPPLEMENTARY METHODS II: SUPPLEMENTARY FIGURES

More information

Development of Next-generation Therapeutic

Development of Next-generation Therapeutic 2015 World Biologics Korea Development of Next-generation Therapeutic Antibodies for Treating Ovarian Cancer (Therapeutic Targeting of Tetraspanin8 in Epithelial Ovarian Cancer Invasion and Metastasis)

More information

The MILE study: Expression microarray analysis for diagnosis of leukaemia. Ken Mills CCRCB Queen s University Belfast

The MILE study: Expression microarray analysis for diagnosis of leukaemia. Ken Mills CCRCB Queen s University Belfast The MILE study: Expression microarray analysis for diagnosis of leukaemia Ken Mills CCRCB Queen s University Belfast Outline MILE Prephase Stage I Stage II Implementation MDS Diagnosis into Prognosis Leukaemia

More information

Digitizing the Proteomes From Big Tissue Biobanks

Digitizing the Proteomes From Big Tissue Biobanks Digitizing the Proteomes From Big Tissue Biobanks Analyzing 24 Proteomes Per Day by Microflow SWATH Acquisition and Spectronaut Pulsar Analysis Jan Muntel 1, Nick Morrice 2, Roland M. Bruderer 1, Lukas

More information

RNA/DNA Stabilization Reagent for Blood/Bone Marrow

RNA/DNA Stabilization Reagent for Blood/Bone Marrow For general laboratory use. Not for use in diagnostic procedures. FOR IN VITRO USE ONLY. RNA/DNA Stabilization Reagent for Blood/Bone Marrow For simultaneous cell lysis and stabilization of nucleic acids

More information

QIAGEN Complete Solutions for Liquid Biopsy Molecular Testing

QIAGEN Complete Solutions for Liquid Biopsy Molecular Testing QIAGEN Complete Solutions for Liquid Biopsy Molecular Testing Christopher Swagell, PhD Market Development Manager, Advanced Molecular Pathology QIAGEN 1 Agenda QIAGEN Solid Tumor Testing and Liquid Biopsy

More information

QIAGEN's Growing Immuno-Oncology Testing Portfolio

QIAGEN's Growing Immuno-Oncology Testing Portfolio QIAGEN's Growing Immuno-Oncology Testing Portfolio QIAGEN Your Partner in Translational Medicine Current Biomarkers of Immuno-Oncology Focus: Immuno-Oncology Testing Portfolio Tumor mutation burden (TMB)

More information

Mechanisms of Resistance to Antiangiogenic. Martin J. Edelman, MD University of Maryland Greenebaum Cancer Center Dresden, 2012

Mechanisms of Resistance to Antiangiogenic. Martin J. Edelman, MD University of Maryland Greenebaum Cancer Center Dresden, 2012 Mechanisms of Resistance to Antiangiogenic Agents Martin J. Edelman, MD University of Maryland Greenebaum Cancer Center Dresden, 2012 Angiogenesis: A fundamental attribute of cancer Premise of Anti-angiogenic

More information

Cardiovascular. Diseases. a simple and standardized kit qpcr analysis of circulating platelet-derived micrornas

Cardiovascular. Diseases. a simple and standardized kit qpcr analysis of circulating platelet-derived micrornas microrna Biomarkers of Platelet Function Neurodegenerative Diseases Cardiovascular Diseases Musculoskeletal Diseases a simple and standardized kit qpcr analysis of circulating platelet-derived micrornas

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Choi YL, Soda M, Yamashita Y, et al. EML4-ALK mutations in

More information

Supporting Information

Supporting Information Supporting Information Bertolini et al. 10.1073/pnas.0905653106 SI Text Lung Tissue Disaggregation. Solid tissues were finely minced by razorblade, washed in DMEM/F12 (Lonza), and then incubated with Accumax

More information

A Phase I Study of RO , a γ-secretase Inhibitor of Notch Signaling, in Patients with Refractory Metastatic or Locally Advanced Solid Tumors

A Phase I Study of RO , a γ-secretase Inhibitor of Notch Signaling, in Patients with Refractory Metastatic or Locally Advanced Solid Tumors A Phase I Study of RO4929097, a γ-secretase Inhibitor of Notch Signaling, in Patients with Refractory Metastatic or Locally Advanced Solid Tumors Tolcher, et al Data Supplement 1 ONLINE APPENDIX Appendix

More information

HER2 status assessment in breast cancer. Marc van de Vijver Academic Medical Centre (AMC), Amsterdam

HER2 status assessment in breast cancer. Marc van de Vijver Academic Medical Centre (AMC), Amsterdam HER2 status assessment in breast cancer Marc van de Vijver Academic Medical Centre (AMC), Amsterdam 13e Bossche Mamma Congres 17 th June 2015 Modern cancer therapies are based on sophisticated molecular

More information

Angiostasis and Angiogenesis Regulated by Angiopoietin1-Tie2 Receptor System

Angiostasis and Angiogenesis Regulated by Angiopoietin1-Tie2 Receptor System Japan-Mexico Workshop on Pharmacology and Nanobiology Feb. 25, 2009; Universidad Nacional Autönoma de Mëxico, Mexico City Angiostasis and Angiogenesis Regulated by Angiopoietin1-Tie2 Receptor System Shigetomo

More information

Study Finds Lung Cancer Subtype Test from UNC, Startup GeneCentric to be Accurate, Reproducible

Study Finds Lung Cancer Subtype Test from UNC, Startup GeneCentric to be Accurate, Reproducible Study Finds Lung Cancer Subtype Test from UNC, Startup GeneCentric to be Accurate, Reproducible May 30, 2013 By Ben Butkus A team led by clinical researchers from the University of North Carolina, Chapel

More information

Supplemental Information. Differential Effects of EGFL6 on Tumor. versus Wound Angiogenesis

Supplemental Information. Differential Effects of EGFL6 on Tumor. versus Wound Angiogenesis Cell Reports, Volume 21 Supplemental Information Differential Effects of EGFL6 on Tumor versus Wound Angiogenesis Kyunghee Noh, Lingegowda S. Mangala, Hee-Dong Han, Ningyan Zhang, Sunila Pradeep, Sherry

More information

CANCER. Clinical Validation of Breast Cancer Predictive Markers

CANCER. Clinical Validation of Breast Cancer Predictive Markers Clinical Validation of Breast Cancer Predictive Markers David Hicks, MD Loralee McMahon, MS, HTL(ASCP) CANCER The human body is composed of billions of highly regulated cells Cancer cells no longer respond

More information

Profili di espressione genica

Profili di espressione genica Profili di espressione genica Giampaolo Bianchini MD Ospedale San Raffaele, Milan - Italy Gene expression profiles Transcriptomics Gene DNA mrna mirnas Protein metilation Metabolite Genomics Transcriptomics

More information

Imaging Cancer Treatment Complications in the Chest

Imaging Cancer Treatment Complications in the Chest Imaging Cancer Treatment Complications in the Chest Michelle S. Ginsberg, MD Objectives Imaging Cancer Treatment Complications in the Chest To understand the mechanisms of action of different classes of

More information

Microvascular rarefaction, angiogenesis and hypertension

Microvascular rarefaction, angiogenesis and hypertension Microvascular rarefaction, angiogenesis and hypertension Bernard I. Lévy PARRC Inserm U970 Institut des Vaisseaux et du Sang Hôpital Lariboisière, Paris. Microcirculation ± 90% of the systemic resistance

More information

Supplementary Figure 1. EC-specific Deletion of Snail1 Does Not Affect EC Apoptosis. (a,b) Cryo-sections of WT (a) and Snail1 LOF (b) embryos at

Supplementary Figure 1. EC-specific Deletion of Snail1 Does Not Affect EC Apoptosis. (a,b) Cryo-sections of WT (a) and Snail1 LOF (b) embryos at Supplementary Figure 1. EC-specific Deletion of Snail1 Does Not Affect EC Apoptosis. (a,b) Cryo-sections of WT (a) and Snail1 LOF (b) embryos at E10.5 were double-stained for TUNEL (red) and PECAM-1 (green).

More information

Ambient Temperature Stabilization of RNA derived from Jurkat, HeLa and HUVEC Cell Lines for Use in RT-qPCR Assays

Ambient Temperature Stabilization of RNA derived from Jurkat, HeLa and HUVEC Cell Lines for Use in RT-qPCR Assays Ambient Temperature Stabilization of RNA derived from Jurkat, HeLa and HUVEC Cell Lines for Use in RT-qPCR Assays C. Litterst 1, H. Martinez, B. Iverson and R. Nuňez 1 Bio-Rad Laboratories, Life Science

More information

For in vitro Veterinary Diagnostics only. Kylt Rotavirus A. Real-Time RT-PCR Detection.

For in vitro Veterinary Diagnostics only. Kylt Rotavirus A. Real-Time RT-PCR Detection. For in vitro Veterinary Diagnostics only. Kylt Rotavirus A Real-Time RT-PCR Detection www.kylt.eu DIRECTION FOR USE Kylt Rotavirus A Real-Time RT-PCR Detection A. General Kylt Rotavirus A products are

More information

RNA extraction, RT-PCR and real-time PCR. Total RNA were extracted using

RNA extraction, RT-PCR and real-time PCR. Total RNA were extracted using Supplementary Information Materials and Methods RNA extraction, RT-PCR and real-time PCR. Total RNA were extracted using Trizol reagent (Invitrogen,Carlsbad, CA) according to the manufacturer's instructions.

More information

1.The metastatic cascade. 2.Pathologic features of metastasis. 3.Therapeutic ramifications

1.The metastatic cascade. 2.Pathologic features of metastasis. 3.Therapeutic ramifications Metastasis 1.The metastatic cascade 2.Pathologic features of metastasis 3.Therapeutic ramifications Sir James Paget (1814-1899) British Surgeon/ Pathologist Paget s disease of bone Paget s disease of the

More information

SMART Digest Kit Facilitating perfect digestion

SMART Digest Kit Facilitating perfect digestion Questions Answers SMART Digest Kit Facilitating perfect digestion The modern biopharmaceutical and protein research laboratory is tasked with providing high quality analytical results, often in high-throughput,

More information

Stergios Moschos, MD

Stergios Moschos, MD Stergios Moschos, MD Clinical Associate Professor of Medicine Department of Medicine Division of Hematology/Oncology University of North Carolina at Chapel Hill Solid Tumor with one of the Highest Mutation

More information

Assessment Run C1 2017

Assessment Run C1 2017 Assessment Run C1 2017 PD-L1 The first assessment in this new NordiQC Companion module C1 focused on the accuracy of the PD-L1 IHC assays performed by the participating laboratories to identify patients

More information

Assessment of Breast Cancer with Borderline HER2 Status Using MIP Microarray

Assessment of Breast Cancer with Borderline HER2 Status Using MIP Microarray Assessment of Breast Cancer with Borderline HER2 Status Using MIP Microarray Hui Chen, Aysegul A Sahin, Xinyan Lu, Lei Huo, Rajesh R Singh, Ronald Abraham, Shumaila Virani, Bal Mukund Mishra, Russell Broaddus,

More information

Abstract. Background. Objective

Abstract. Background. Objective Molecular epidemiology of clinical tissues with multi-parameter IHC Poster 237 J Ruan 1, T Hope 1, J Rheinhardt 2, D Wang 2, R Levenson 1, T Nielsen 3, H Gardner 2, C Hoyt 1 1 CRi, Woburn, Massachusetts,

More information

Supplementary webappendix

Supplementary webappendix Supplementary webappendix This webappendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Kratz JR, He J, Van Den Eeden SK, et

More information

Assessment of Microvessel Density (Angiogenesis) And Its Correlation with Tumor Grade

Assessment of Microvessel Density (Angiogenesis) And Its Correlation with Tumor Grade IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 16, Issue 3 Ver. XI (March. 2017), PP 15-19 www.iosrjournals.org Assessment of Microvessel Density (Angiogenesis)

More information

CHMP Oncology Working Party Workshop on: Histology Independent Indications in Oncology. Non-clinical models: Tumour Models - Proof of Concept

CHMP Oncology Working Party Workshop on: Histology Independent Indications in Oncology. Non-clinical models: Tumour Models - Proof of Concept CHMP Oncology Working Party Workshop on: Histology Independent Indications in Oncology Non-clinical models: Tumour Models - Proof of Concept Edward C. Rosfjord Pfizer Worldwide R. & D. 14 December 2017

More information

Integrin v 3 targeted therapy for Kaposi s sarcoma with an in vitro evolved antibody 1

Integrin v 3 targeted therapy for Kaposi s sarcoma with an in vitro evolved antibody 1 Integrin v 3 targeted therapy for Kaposi s sarcoma with an in vitro evolved antibody 1 CHRISTOPH RADER, 2 MIKHAIL POPKOV, JOHN A. NEVES, AND CARLOS F. BARBAS III 2 Department of Molecular Biology and The

More information

EPIGENOMICS PROFILING SERVICES

EPIGENOMICS PROFILING SERVICES EPIGENOMICS PROFILING SERVICES Chromatin analysis DNA methylation analysis RNA-seq analysis Diagenode helps you uncover the mysteries of epigenetics PAGE 3 Integrative epigenomics analysis DNA methylation

More information

NCRI Biomarkers & Imaging CSG Cell-free DNA workshop

NCRI Biomarkers & Imaging CSG Cell-free DNA workshop NCRI Biomarkers & Imaging CSG Cell-free DNA workshop Workshop Report Christie Education Centre, Manchester 30th January 2014 Sponsored by Workshop summary 86 delegates from a variety of specialities attended

More information

Investor Update. Basel, 21 October 2018

Investor Update. Basel, 21 October 2018 Investor Update Basel, 21 October 2018 Updated data showed that Roche's Tecentriq in combination with Avastin shrank tumours in people with unresectable or advanced hepatocellular carcinoma (HCC) Data

More information

A263 A352 A204. Pan CK. pstat STAT3 pstat3 STAT3 pstat3. Columns Columns 1-6 Positive control. Omentum. Rectosigmoid A195.

A263 A352 A204. Pan CK. pstat STAT3 pstat3 STAT3 pstat3. Columns Columns 1-6 Positive control. Omentum. Rectosigmoid A195. pstat3 75 Pan CK A A263 A352 A24 B Columns 1-6 Positive control A195 A22 A24 A183 Rectal Nodule STAT3 pstat3 STAT3 pstat3 Columns 7-12 Omentum Rectosigmoid Left Ovary Right Ovary Omentum Uterus Uterus

More information

EXO-DNA Circulating and EV-associated DNA extraction kit

EXO-DNA Circulating and EV-associated DNA extraction kit Datasheet EXO-DNA Circulating and EV-associated DNA extraction kit This product is for research use only. It is highly recommended to read this users guide in its entirety prior to using this product.

More information

Layered-IHC (L-IHC): A novel and robust approach to multiplexed immunohistochemistry So many markers and so little tissue

Layered-IHC (L-IHC): A novel and robust approach to multiplexed immunohistochemistry So many markers and so little tissue Page 1 The need for multiplex detection of tissue biomarkers. There is a constant and growing demand for increased biomarker analysis in human tissue specimens. Analysis of tissue biomarkers is key to

More information

Method of data collection: Clinical details were obtained for 50 IDC-NOS cases

Method of data collection: Clinical details were obtained for 50 IDC-NOS cases Assessment of Microvessel Density (Angiogenesis) and its Correlation with Hormonal Status of Carcinoma Breast Dr. P. Vijaya Baskar 1, Dr. M. Gunasundari 2 1, 2 Institute of Pathology, Madras Medical College,

More information

For focused group profiling of human HIV infection and host response genes expression

For focused group profiling of human HIV infection and host response genes expression ExProfile TM Human HIV Infection and Host Response Related Gene qpcr Array For focused group profiling of human HIV infection and host response genes expression Cat. No. QG023-A (1 x 96-well plate, Format

More information

Enterprise Interest None

Enterprise Interest None Enterprise Interest None Hypoxic Gene Signature of Primary and Metastatic Melanoma Cell Lines: Focusing on HIF1-Beta and NDRG-1 Mustafa Emre Ercin,MD Department of Pathology, Karadeniz Technical University

More information

SALSA MLPA probemix P315-B1 EGFR

SALSA MLPA probemix P315-B1 EGFR SALSA MLPA probemix P315-B1 EGFR Lot B1-0215 and B1-0112. As compared to the previous A1 version (lot 0208), two mutation-specific probes for the EGFR mutations L858R and T709M as well as one additional

More information

altona RealStar Instructions for Use RealStar CMV PCR Kit /2017 EN DIAGNOSTICS

altona RealStar Instructions for Use RealStar CMV PCR Kit /2017 EN DIAGNOSTICS altona DIAGNOSTICS Instructions for Use RealStar CMV PCR Kit 1.2 08/2017 EN RealStar RealStar CMV PCR Kit 1.2 For research use only! (RUO) 021202 INS-021200-EN-S01 48 08 2017 altona Diagnostics GmbH Mörkenstr.

More information

HER2 ISH (BRISH or FISH)

HER2 ISH (BRISH or FISH) Assessment Run H14 2018 HER2 ISH (BRISH or FISH) Material Table 1. Content of the multi-block used for the NordiQC HER2 ISH assessment, run H14 HER2 IHC* IHC score Dual - SISH** FISH*** FISH*** HER2/chr17

More information

Media Release. Basel, 7 May 2018

Media Release. Basel, 7 May 2018 Media Release Basel, 7 May 2018 FDA grants priority review to Roche s cancer immunotherapy TECENTRIQ (atezolizumab) for initial treatment of people with a specific type of metastatic lung cancer Roche

More information

Breast Cancer: the interplay of biology, drugs, radiation. Prof. L. Livi Università degli Studi di Firenze. Brescia, October 3rd 4th, 2013

Breast Cancer: the interplay of biology, drugs, radiation. Prof. L. Livi Università degli Studi di Firenze. Brescia, October 3rd 4th, 2013 Breast Cancer: the interplay of biology, drugs, radiation Prof. L. Livi Università degli Studi di Firenze Brescia, October 3rd 4th, 2013 BACKGROUND (1) The complex interactions between tumor-specific signaling

More information